Caterina Foti Selected Research

Therapeutics

2/2024	Pembrolizumab-Induced Rupioid Psoriasis Treated by Apremilast Without Interrupting the Ongoing Antineoplastic Treatment.
3/2023	Photodynamic Therapy Used to Treat an HIV Patient with an Efflorescence of Viral Warts after HAART Therapy.
1/2023	Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma.
1/2023	Is Adrenaline Always the First Choice Therapy of Anaphylaxis? An Allergist-cardiologist Interdisciplinary Point of View.
8/2022	Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities.
8/2022	Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection.
4/2022	Spreading Allergic Contact Dermatitis to Tea Tree Oil in an Over-the-Counter Product Applied on a Wart.
3/2022	Balloon Cell Melanoma: Presentation of Four Cases with a Comprehensive Review of the Literature.
7/2021	Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives.
1/2021	Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Foti Research Topics

Disease

46	Allergic Contact Dermatitis 04/2024 - 05/2002
44	Hypersensitivity (Allergy) 01/2024 - 04/2003
17	Contact Dermatitis (Eczema, Contact) 01/2024 - 11/2002
12	Dermatitis 02/2024 - 11/2005
12	Atopic Dermatitis (Atopic Eczema) 01/2024 - 03/2005
10	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 05/2015
8	Eczema 10/2022 - 06/2007
6	Urticaria (Hives) 01/2021 - 01/2012
5	Skin Diseases (Skin Disease) 04/2024 - 03/2010
5	Acne Vulgaris 01/2024 - 09/2015
5	Neoplasms (Cancer) 01/2024 - 11/2021
5	Melanoma (Melanoma, Malignant) 01/2024 - 01/2009
5	Chronic Urticaria 11/2023 - 06/2018
5	COVID-19 10/2023 - 07/2020
5	Infections 10/2023 - 01/2002
5	Exanthema (Rash) 03/2023 - 02/2013
4	Anaphylaxis (Anaphylactic Shock) 01/2023 - 01/2009
4	Angioedema 01/2022 - 01/2012
3	Erythema 01/2024 - 09/2015
3	Warts (Wart) 03/2023 - 03/2022
3	Pruritus (Itching) 01/2022 - 09/2013
3	Photoallergic Dermatitis (Photoallergy) 01/2022 - 06/2010
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2024 - 06/2005
2	Mastocytosis 10/2023 - 12/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2022
2	Gout 01/2022 - 02/2013
2	Cheilitis 08/2020 - 07/2014
2	Drug Hypersensitivity Syndrome 07/2020 - 11/2012
2	Erythema Multiforme 11/2017 - 09/2008
2	Leg Ulcer 06/2016 - 07/2007
2	Ulcer 07/2007 - 06/2007
1	Adenocarcinoma 02/2024
1	Unconsciousness (Loss of Consciousness) 01/2024
1	Hypercholesterolemia 01/2024

Drug/Important Bio-Agent (IBA)

13	AllergensIBA 04/2024 - 01/2009
8	Omalizumab (Xolair)FDA Link 11/2023 - 06/2018
7	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 03/2005
6	dupilumabIBA 01/2024 - 01/2020
6	Irritants (Vesicants)IBA 01/2024 - 05/2003
5	secukinumabIBA 05/2024 - 11/2020
5	NickelIBA 01/2024 - 06/2005
5	VaccinesIBA 10/2023 - 03/2022
5	Proteins (Proteins, Gene)FDA Link 08/2023 - 11/2012
4	BNT162 VaccineIBA 02/2023 - 07/2021
4	CosmeticsIBA 11/2022 - 10/2017
4	anti-IgE antibodiesIBA 01/2022 - 01/2019
4	Ointments (Pastes)IBA 12/2008 - 11/2005
3	EnzymesIBA 01/2024 - 01/2021
3	Excipients (Suspending Agents)IBA 01/2023 - 01/2016
3	EmollientsIBA 10/2022 - 05/2010
3	AcrylatesIBA 08/2020 - 04/2018
3	MethacrylatesIBA 04/2020 - 01/2018
2	apremilastIBA 02/2024 - 01/2021
2	upadacitinibIBA 01/2024 - 01/2024
2	1,2-pentanediolIBA 12/2023 - 05/2010
2	Messenger RNA (mRNA)IBA 10/2023 - 03/2022
2	2019-nCoV Vaccine mRNA-1273IBA 03/2023 - 02/2023
2	AntigensIBA 12/2022 - 09/2022
2	VitaminsIBA 11/2022 - 01/2021
2	InterleukinsIBA 08/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2022 - 01/2020
2	Microbial Collagenase (Clostridiopeptidase A)FDA Link 02/2022 - 06/2007
2	Promazine (Promazine Hydrochloride)FDA Link 01/2022 - 09/2017
2	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 11/2018
2	SteroidsIBA 07/2021 - 01/2009
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2021 - 12/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 11/2017
2	CytokinesIBA 01/2021 - 11/2017
2	PolyphenolsIBA 01/2021 - 11/2017
2	Histamine Antagonists (Antihistamines)IBA 01/2021 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 01/2019
2	acrylic acid (acrylate)IBA 04/2020 - 01/2018
2	3-dimethylaminopropylamineIBA 04/2020 - 04/2003
2	thienopyridineIBA 01/2020 - 01/2019
2	ThienopyridinesIBA 01/2020 - 01/2019
2	Clopidogrel (Plavix)FDA Link 01/2020 - 01/2019
2	isobornyl acrylateIBA 11/2018 - 01/2016
2	4-phenylenediamine (p-phenylenediamine)FDA Link 07/2018 - 12/2010
2	CyanoacrylatesIBA 04/2018 - 05/2003
2	2-methyl-4-isothiazolin-3-oneIBA 04/2018 - 05/2017
2	RetinoidsIBA 09/2017 - 09/2015
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2017 - 07/2009
2	Epoxy Resins FDA Link 01/2013 - 09/2010
2	Immunoglobulin E (IgE)IBA 11/2012 - 01/2002
2	Ketoprofen (Orudis)FDA LinkGeneric 03/2011 - 03/2011
2	Cod Liver OilIBA 12/2008 - 10/2007
2	Cyanamide (Calcium Carbimide)IBA 01/2008 - 05/2003
2	IntegrinsIBA 02/2007 - 01/2004
1	Pemetrexed (MTA)FDA Link 02/2024
1	pembrolizumabIBA 02/2024
1	Cisplatin (Platino)FDA LinkGeneric 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 02/2024
1	Acitretin FDA Link 02/2024
1	Surface-Active Agents (Surfactants)IBA 01/2024
1	sorbitan sesquioleateIBA 01/2024

Therapy/Procedure

20	Therapeutics 02/2024 - 11/2004
3	Tattooing 01/2024 - 12/2010
2	Immunotherapy 02/2024 - 01/2023
2	Aftercare (After-Treatment) 03/2023 - 01/2022
2	Biological Therapy 08/2022 - 12/2021